These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11683252)

  • 21. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH; DeLuca PP
    Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach to bioconjugates for proteins and peptides ("pegylation") utilising living radical polymerisation.
    Lecolley F; Tao L; Mantovani G; Durkin I; Lautru S; Haddleton DM
    Chem Commun (Camb); 2004 Sep; (18):2026-7. PubMed ID: 15367957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of copper-catalyzed azide-alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation.
    Nairn NW; Shanebeck KD; Wang A; Graddis TJ; VanBrunt MP; Thornton KC; Grabstein K
    Bioconjug Chem; 2012 Oct; 23(10):2087-97. PubMed ID: 22988919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed mutagenesis and chemical modification of histidine residues on an alpha-class chick liver glutathione S-transferase CL 3-3. Histidines are not needed for the activity of the enzyme and diethylpyrocarbonate modifies both histidine and lysine residues.
    Chang LH; Tam MF
    Eur J Biochem; 1993 Feb; 211(3):805-11. PubMed ID: 8436137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
    Lu YA; Felix AM
    Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative understanding of pH- and salt-mediated conformational folding of histidine-containing, β-hairpin-like peptides, through single-molecule probing with protein nanopores.
    Mereuta L; Asandei A; Seo CH; Park Y; Luchian T
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):13242-56. PubMed ID: 25069106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
    Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
    J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Bioconjugation Strategy Using Elevated Hydrostatic Pressure: A Case Study for the Site-Specific Attachment of Polyethylene Glycol (PEGylation) of Recombinant Human Ciliary Neurotrophic Factor.
    Wang Q; Zhang C; Guo F; Li Z; Liu Y; Su Z
    Bioconjug Chem; 2017 Nov; 28(11):2841-2848. PubMed ID: 29053917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the structure of pegylated-recombinant protein therapeutics by the NMR fingerprint assay.
    Hodgson DJ; Aubin Y
    J Pharm Biomed Anal; 2017 May; 138():351-356. PubMed ID: 28254519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.
    Bobst CE; Abzalimov RR; Houde D; Kloczewiak M; Mhatre R; Berkowitz SA; Kaltashov IA
    Anal Chem; 2008 Oct; 80(19):7473-81. PubMed ID: 18729476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG chain length impacts yield of solid-phase protein PEGylation and efficiency of PEGylated protein separation by ion-exchange chromatography: insights of mechanistic models.
    Yoshimoto N; Isakari Y; Itoh D; Yamamoto S
    Biotechnol J; 2013 Jul; 8(7):801-10. PubMed ID: 23788446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
    Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
    Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and biophysical characterization of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers.
    Dhalluin C; Ross A; Leuthold LA; Foser S; Gsell B; Müller F; Senn H
    Bioconjug Chem; 2005; 16(3):504-17. PubMed ID: 15898716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEGylation of native disulfide bonds in proteins.
    Brocchini S; Balan S; Godwin A; Choi JW; Zloh M; Shaunak S
    Nat Protoc; 2006; 1(5):2241-52. PubMed ID: 17406463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
    Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
    Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.